Life Sciences
Our global Life Sciences team comprises a multi-disciplinary group of professionals, acting for businesses across the pharmaceuticals, biotech, veterinary, consumer health, med tech, and diagnostics sub-sectors.
Our experts advise across the entire product cycle - from product development, clinical trials to market entry, advice on reimbursement claims in Germany and pan-European locations, and post-market pharmacovigilance.
The sector team operates on a cross-border basis and covers the full spectrum of legal support. We advise on mergers and acquisitions, IP (both contentious and non-contentious), regulatory, dispute resolution, commercial transactions (including licensing and collaborations) as well as capital markets and finance.
Our international network ensures that we have a ready resource of expertise in a number of jurisdictions, including those in emerging markets, and that we are in the pole position to advise on cross-border work.
Meet our lawyers
News and insights
Blog Post: 28 November 2022
Webinar - EU developments in pricing and reimbursement
Keeping up with current developments regarding pricing and reimbursement of pharmaceuticals is crucial for planning efficient and successful market access strategies. The regulatory framework…
Publications: 28 July 2022
Equity capital markets in 2022: Europe cools, the Middle East heats up. What next?
The equity capital markets have faced challenging conditions in H1 2022. European markets cooled, the Middle East boomed.
Publications: 20 January 2022
Kickoff of the UPC: UPC Protocol on Provisional Application now in force
On 19 January 2022, the Unified Patent Court (UPC) came to life as an international organisation. Now, the preparatory phase for the official start of the UPC system can begin.
Publications: 09 July 2021
German Federal Constitutional Court paves the way for the UPC
As an international treaty the Agreement on a Unified Patent Court (UPCA) provides for the establishment of the Unified Patent Court (UPC). As a joint Court of the Contracting Member States, the UPC…
Life Sciences Hub
